Abstract
Many biomineralization processes involve the sequestering of ions by cells and their translocation through the cells to the final deposition site. In many invertebrate crystallization pathways the cells deposit an initial highly disordered mineral phase with intracellular vesicles, and this mineral is subsequently transported into the final deposition site outside the cell. As this initial mineral phase is metastable, it can easily dissolve or crystallize during sample preparation and examination. A cryogenic electron microscopy study of the forming fin bone of a zebra fish strain with continuously growing fins shows that the cells responsible for bone tissue formation do have mineral-bearing intracellular vesicles and that the mineral phase is a highly disordered calcium phosphate. We also show that globules of disordered calcium phosphate are present in the extracellular collageneous matrix and that they are not membrane bound. Close to the mineralization front these globules appear to penetrate into the collagen fibrils where they crystallize to form mature bone. This crystallization pathway is similar to pathways observed in invertebrates, and it differs from the matrix vesicle pathway documented for a variety of vertebrate mineralizing tissues as the extracellular mineral globules are not membrane bound.
References
1.
Adrian, M., J. Dubochet, J. Lepault, A.W. McDowall (1984) Cryoelectron microscopy of viruses. Nature 308: 32–36.
2.
Anderson, H.C., R. Garimella, S.E. Tague (2005) The role of matrix vesicles in growth plate development and biomineralization. Front Biosci 10: 822–837.
3.
Crane, N.J., V. Popescu, M.D. Morris, P. Steenhuis, M.A. Ignelzi (2006) Raman spectroscopic evidence for octacalcium phosphate and other mineral species deposited during intramembranous mineralization. Bone 39: 431–433.
4.
Fratzl-Zelman, N., P. Fratzl, H. Horandner, B. Grabner, F. Varga, A. Ellinger, K. Klaushofer (1998) Matrix mineralization in MC3T3-E1 cell cultures initiated by β-glycerolphosphate pulse. Bone 23: 511–520.
5.
Garimella, R., X. Bi, H.C. Anderson, N.P. Camacho (2006) Nature of phosphate substrate as a major determinant of mineral type formed in matrix vesicle-mediated in vitro mineralization: an FTIR imaging study. Bone 38: 811–817.
6.
Gay, C.V, H. Schraer (1975) Frozen thin-sections of rapidly forming bone: bone cell ultrastructure. Calcif Tissue Res 19: 39–49.
7.
Ge, J., X.M. Wang, F.Z. Cui (2006) Microstructural characteristics and nanomechanical properties across the thickness of the wild-type zebrafish skeletal bone. Mater Sci Eng 26: 710–715.
8.
Gerstenfeld, L.C., S.D. Chipman, C.M. Kelly, K.J. Hodgens, D.D. Lee, W.J. Landis (1988) Collagen expression, ultrastructural assembly, and mineralization in cultures of chicken embryo osteoblasts. J Cell Biol 106: 979–989.
9.
Khouja, H.I., A. Bevington, G.J. Kemp, R.G.G. Russel (1990) Calcium and orthophosphate deposits in vitro do not imply osteoblast-mediated mineralization: mineralization by betaglycerophosphate in the absence of osteoblasts. Bone 11: 385–391.
10.
Landis, W.J., J. Geraudie (1990) Organization and development of the mineral phase during early ontogenesis of the bony fin rays of the trout Oncorhynchus mykiss. Anat Rec 228: 383–391.
11.
Landis, W.J., M.C. Paine, M.J. Glimcher (1980) Use of acrolein vapors for the anhydrous preparation of bone tissue for electron microscopy. J Ultrastruct. Res 70: 171–180.
12.
Mahamid, J., B. Aichmayer, E. Shimoni, R Ziblat., C. Li, S. Siegel, O. Paris, P. Fratzl, S. Weiner, L. Addadi (2010) Mapping amorphous calcium phosphate transformation into crystalline mineral from the cell to the bone in zebrafish fin rays. Proc Natl Acad Sci USA 107: 6316–6321.
13.
Mahamid, J., A. Sharir, L. Addadi, S. Weiner (2008) Amorphous calcium phosphate is a major component of the forming fin bones of zebrafish: indications for an amorphous precursor phase. Proc Natl Acad Sci USA 105: 12748–12753.
14.
Mahamid, J., A. Sharir, D. Gur, E. Zelzer, L. Addadi, S. Weiner (2011) Bone mineralization proceeds through intracellular calcium phosphate loaded vesicles: a cryo-electron microscopy study. J Struct Biol, in press.
15.
Nudelman, F., K. Pirterse, A. George, P.H. Bomans, H. Friedrich, L.J. Brylka, P.A.J. Hilbers, G. de With, N.A. Sommerdijk (2010) The role of collagen in bone apatite formation in the presence of hydroxyapatite nucleation inhibitors. Nat Mater 9: 1004–1009.
16.
Olszta, M.J., X. Cheng, S.S. Jee, R. Kumar, Y.Y. Kim, M.J. Kaufman, E.P. Douglas, L.B. Gower (2007) Bone structure and formation: a new perspective. Mater Sci Eng 58: 77–116.
17.
Price, P.A., D. Toroian, J.E. Lim (2009) Mineralization by inhibitor exclusion: the calcification of collagen with fetuin. J Biol Chem 284: 17092–17101.
18.
Richter, T., S.S. Biel, M. Sattler, H. Wenck, K.P. Wittern, R. Wiesendanger, R. Wepf (2007) Pros and cons: cryo-electron microscopic evaluation of block faces versus cryo-sections from frozen-hydrated skin specimens prepared by different techniques. J Microsc 225: 201–207.
19.
Sabanay, I., T. Arad, S. Weiner, B. Geiger (1991) Study of vitrified, unstained frozen tissue sections by cryoimmunoelectron microscopy. J Cell Sci 100: 227–236.
20.
Schraer, H., C.V. Gay (1977) Matrix vesicles in newly synthesizing bone observed after ultracryotomy and ultramicroincineration. Calcif Tissue Res 23: 185–188.
21.
Weiner, S., J. Mahamid, Y. Politi, Y. Ma, L. Addadi (2009) Overview of the amorphous precursor phase strategy in biomineralization. Front Mater Sci China 3: 104–108.
22.
Weiner, S., L. Addadi (2011) Crystallization pathways in biomineralization. Annu Rev Mater Res, in press.
23.
Wu, L.N.Y., B.R. Genge, D.G. Dunkelberger, R.Z. LeGeros, B. Concannon, R.E. Wuthier (1997) Physicochemical characterization of the nucleational core of matrix vesicles. J Biol Chem 272: 4401–4411.
24.
Wuthier, R.E., E.D. Eanes (1975) Effect of phospholipids on the transformation of amorphous calcium phosphate to hydroxyapatite in vitro. Calcif Tissue Res 19: 197–210.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
